Unicycive Therapeutics Inc (UNCY)

06:55 AM

Why Unicycive Therapeutics Inc. stock remains resilientLong Setup & Fast Entry and Exit Trade Plans - newser.com

06:55 AM

06:15 AM

Is Unicycive Therapeutics Inc. meeting your algorithmic filter criteriaPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com

06:15 AM

05:21 AM

Can Unicycive Therapeutics Inc. stock sustain institutional interestProduct Launch & Stepwise Trade Signal Implementation - newser.com

05:21 AM

04:26 AM

How Unicycive Therapeutics Inc. stock compares to growth peers2025 Technical Overview & Low Drawdown Investment Strategies - newser.com

04:26 AM

04:10 AM

Live market analysis of Unicycive Therapeutics Inc.Weekly Earnings Recap & Verified Momentum Stock Alerts - newser.com

04:10 AM

02:17 AM

What catalysts could drive Unicycive Therapeutics Inc. stock higherJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com

02:17 AM

Nov 03, 2025

Unicycive Therapeutics, Inc. (UNCY) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 03, 2025

Nov 03, 2025

Unicycive Therapeutics price target raised to $22 from $9 at H.C. Wainwright - MSN

Nov 03, 2025

Nov 03, 2025

How rising interest rates impact Unicycive Therapeutics Inc. stockWeekly Stock Report & Fast Moving Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Sentiment analysis tools applied to Unicycive Therapeutics Inc.2025 Earnings Surprises & Verified Entry Point Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Unicycive Therapeutics to Participate in a Fireside Chat at - GlobeNewswire

Nov 03, 2025

Nov 03, 2025

What moving averages say about Unicycive Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Unicycive Therapeutics Inc. stock beat EPS estimates2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com

Nov 03, 2025

Nov 02, 2025

Can Unicycive Therapeutics Inc. stock hit analyst price targetsJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com

Nov 02, 2025

Nov 02, 2025

Unicycive Therapeutics, Inc. (UNCY) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 02, 2025

Nov 02, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Connect - ACCESS Newswire

Nov 02, 2025

Nov 02, 2025

Does Unicycive Therapeutics Inc. show high probability of reboundJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com

Nov 02, 2025

Nov 02, 2025

Identifying reversal signals in Unicycive Therapeutics Inc.2025 Geopolitical Influence & Consistent Profit Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Raised to Hold at Wall Street Zen - MarketBeat

Nov 02, 2025

Nov 01, 2025

HC Wainwright Analysts Increase Earnings Estimates for UNCY - MarketBeat

Nov 01, 2025

Oct 31, 2025

Unicycive Leaders Sued for Touting Kidney Treatment’s Prospects - Bloomberg Law News

Oct 31, 2025

Oct 31, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat

Oct 31, 2025

Oct 31, 2025

UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. ... - Bluefield Daily Telegraph

Oct 31, 2025

Oct 31, 2025

UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Oct 31, 2025

Oct 31, 2025

Unicycive Therapeutics - Nasdaq

Oct 31, 2025

Oct 31, 2025

Custom strategy builders for tracking Unicycive Therapeutics Inc.Trade Entry Report & Long-Term Investment Growth Plans - newser.com

Oct 31, 2025

Oct 31, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), United Therapeutics (UTHR) and Unicycive Therapeutics (UNCY) - The Globe and Mail

Oct 31, 2025

Oct 31, 2025

How Unicycive Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com

Oct 31, 2025

Oct 31, 2025

Optimistic Buy Rating for Unicycive Therapeutics Driven by Promising Clinical Progress and Financial Stability - TipRanks

Oct 31, 2025

Oct 31, 2025

Analyzing net buyer seller activity in Unicycive Therapeutics Inc.2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com

Oct 31, 2025

Oct 31, 2025

Will a bounce in Unicycive Therapeutics Inc. offer an exit2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com

Oct 31, 2025

Oct 30, 2025

Guggenheim Sticks to Its Buy Rating for Unicycive Therapeutics (UNCY) - The Globe and Mail

Oct 30, 2025

Oct 30, 2025

Benchmark Co. Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Oct 30, 2025

Oct 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Connect - ACCESS Newswire

Oct 30, 2025

Oct 30, 2025

Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference - The Manila Times

Oct 30, 2025

Oct 30, 2025

Unicycive Therapeutics to Present New Data for Oxylanthanum Carbonate at ASN Kidney Week 2025 - Quiver Quantitative

Oct 30, 2025

Oct 30, 2025

Unicycive (NASDAQ: UNCY) to present OLC data: 7x lower pill volume, 2x fewer pills at ASN - Stock Titan

Oct 30, 2025

Oct 30, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alkermes (ALKS), Arcutis Biotherapeutics (ARQT) and Unicycive Therapeutics (UNCY) - The Globe and Mail

Oct 30, 2025